Skip To The Main Content
2021 QR_1988x680

2021 PDA Quality and Regulations Conference

A New Risk Landscape in an Evolving Quality and Regulatory Environment

Oct 19 - Oct 20, 2021
Central Europe Standard Time | Online
  • Virtual
  • Europe
Register Now
Program Highlights

The 2021 conference will again be held as a virtual event.
The PDA Europe online platform will offer various interactive options online!

Don’t miss hearing updates on international regulations and make sure to join us this Fall!

Sign up today!

Overview

Dear Colleagues,

The manufacture of drugs, drug products, and combination products is one of the most closely regulated activities in the industry. The core of Good Manufacturing Practice is defined and determined by a variety of guidelines and regulations issued and updated regularly by national and international authorities. These have direct implications for the development, manufacturing, and reliable distribution of pharmaceutical products in regular times and even more so during a pandemic.

This and more will be the focus of the 2021 PDA Quality and Regulations Conference, set to take place online 19-20 October!

By joining this two-day event, you will be presented the most current and thorough information on recent and most important changes in the regulatory landscape. Receive direct feedback on your questions from distinguished experts in live Q&A and discussion sessions!

In the era of breakthrough medicinal therapies and technologies, accelerated R&D, Lifecycle and Change Management, Knowledge and Risk Management become pivotal milestones to ensure availability of these drugs.

Dive into the new decade with PDA by exploring digital solutions in Quality and don’t miss out on learnings on Control & Risk Strategies and the latest trends!

We look forward to welcoming you online this Fall!

Sincerely,

The Chairs

Vinny Browning III, Amgen
Karin Baer, NeuroDerm

SCIENTIFIC PROGRAM PLANNING COMMITTEE

Vinny Browning III, Amgen - Chair
Karin Baer, NeuroDerm - Chair
Graham Cook, Pfizer
Patrick Costello, AbbVie
Travis Frick, Istari Oncology
Peter Reichert, Zelect
Eva Urban, CSL Behring
Ruth Miller, PDA
Falk Klar, PDA Europe
Sylvia Becker, PDA Europe, Senior Manager Programs & Events

Stay Informed Ask a Question

Agenda

  • Day 1
  • Day 2

  • Tuesday, 19 October 2021

    Module I: Welcome & International Regulatory Updates
    12:00-14:45 CEST

    Welcome & Introductions Falk Klar, PDA Europe
    Welcome from the Chairs Vinny Browning III, Amgen
    Karin Baer,
    NeuroDerm

    Keynote Presentation:
    Key Developments and Learnings from the Ongoing Pandemic

    Speaker,
    invited

    Live Session Introduction:
    International Regulatory Updates

    Moderators:
    Vinny Browning III,
    Amgen

    Karin Baer,
    NeuroDerm
    Update on Agency Activities Brendan Cuddy,
    European Medicines Agency
    New Regulatory Initiatives in the UK for Innovative Medicines - Innovative Licensing and Access Pathway (ILAP) & ‘Point of Care’ (POC) Manufacturing for Personalized Medicines Philip Rose,
    MHRA
    Aseptic Processes in the Production of Medicinal Products in Accordance with US FDA and the Eurasian Economic Union’s Guideline Dmitriy Rozhdestvenskiy,
    Eurasian Economic Commission
    Updates and a Perspective on ICH Q12 Implementation in Japan Yasuhiro Kishioka,
    PMDA

    Live Q & A, Discussion


    Break, Exhibition & Poster Session 
    14:45-15:30 CEST

    Module II: International Perspectives: Remote Inspections
    15:30-18:15 CEST

    Live Session Introduction:
    International Perspectives: Remote Inspections

    Moderator:
    Graham Cook,
    Pfizer

    Glenn Wright,
    PDA
    Hosting Remote Inspections by Russian and EU Regulators Elizabeth Meyers, Amgen
    Russian GMP Inspectorate’s Perspective Vladislav Shestakov,
    State Institute of Drugs and Good Practices
    Conducting Remote GMP Inspections of API Manufacturers in Real Time Thomas Hecker,
    EDQM
    New Opportunities and Challenges in Conforming with Compliance in Inspections Stephan Roenninger,
    Amgen
    Industry Perspective: PDA Points to Consider on Remote Inspections Eva Urban,
    CSL Behring

    Live Q & A, Panel Discussion
    Program Agenda subject to confirmation and change without prior notice.

  • Wednesday, 20 October 2021

    Module III: Quality & Regulations in Times of a Pandemic
    12:00-14:00 CEST

    Live Session Introduction:
    Quality & Regulations in Times of a Pandemic

    Moderators:
    Patrick Costello,
    AbbVie

    Travis Frick,
    Istari Oncology
    FDA Guidance Update: COVID-Related Quality Policies Ashley Boam,
    US FDA
    USP’s Evolving Approaches to Compendial Standards Fouad Atouf,
    United States Pharmacopeia

    Moving towards Compliance to MDR Article 117 – Many Unanswered Questions

    		 Bettine Boltres,
    WEST
    Handling Out of Specification Test Results Elissa Hilton,
    Eli Lilly & Co.

    Live Q & A, Panel Discussion


    Break, Exhibition & Poster Session 
    14:00-15:00 CEST

    Module IV: Quality Risk Management
    15:00-17:00 CEST

    Live Session Introduction:
    Quality Risk Management

    Moderators:
    Eva Urban,
    CSL Behring

    Karin Baer,
    NeuroDerm
    Seeking the Diamonds - From QRM to PQS Decision-Making Valerie Mulholland,
    GMP Services Ltd
    Utilization of A Quality Risk Management Approach Janmeet Anant,
    Merck KGaA
    A Holistic Approach to Virus Risk Assessment and Controls in A Drug Substance Ballroom Facility Joe Jerkins,
    Genentech

    Live Q & A, Discussion

    Conference Summary by the Chairs

    		 Vinny Browning III, Amgen
    Karin Baer, NeuroDerm

    Thank you, Chair Awards, Outlook and Farewell

    		 Falk Klar, PDA Europe

Highlighted Speakers

Fouad Atouf
Fouad Atouf
USP
Ashley B. Boam
Ashley B. Boam
U.S. FDA
Bettine Boltres
Bettine Boltres
West Pharmaceutical Services
Brendan Cuddy
Brendan Cuddy
European Medicines Agency (EMA)
Elizabeth Meyers
Elizabeth Meyers
Amgen

Who Should Attend

  • Quality Assurance
  • Quality Affairs/External Affairs
  • Regulatory Affairs
  • Consultants Regulatory agency employees from international agencies Manufacturing
  • Quality Control

Registration Fees

Register Now
Early Registration
Registration Type Price before 29 August 2021
virtual Member €1.395
virtual Non-Member €1.695
virtual Govern./Health Authority/Academic/
Young Professionals (Member)		 €600

All fees given in Euro, excluding VAT

Regular Registration
Registration Type Price after 29 August 2021
virtual Member €1.595
virtual Non-Member €1.895
virtual Govern./Health Authority/Academic/
Young Professionals (Member)		 €600

All fees given in Euro, excluding VAT

Got a Question? We have answers

Contact Us
Become a Sponsor

Interested in becoming a sponsor? Learn about opportunities and benefits.

Request Information

Exhibitors

Become an Exhibitor

Interested in becoming an exhibitor? Learn about opportunities and benefits.

Request Information
Exhibitor Standard Contract Clause

Attendee List Email Scam

Unfortunately, emails are circulating that offer to sell attendee lists for many of PDA’s conferences and events. These emails are sent by scammers.

Note: PDA does not sell its exhibitor or attendee lists, and no third-party is authorized to distribute or sell any lists related to our events. Statements claiming to offer our attendee lists are fraudulent. If you receive emails that propose to sell PDA conference attendee lists, do not engage with the sender and delete the message immediately.

Media Partners

Contact

Program Inquiries
Exhibition Inquiries
Course Inquiries
Registration Customer Care

Tel: +1 (301) 656-5900 ext. 115
[email protected]

PDA Members Save Substantially